Electronic Monitoring Feedback for Improving Medication Adherence and Clinical Outcomes in Early Rheumatoid Arthritis: A Randomized Clinical Trial

References

• Smolen JS, Landewé R, Bijlsma J, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017;76:960–977. doi:10.1136/annrheumdis-2016-210715
   PubMed Web of Science ®Google Scholar
• Waimann C, Marengo M, Achaval de S, et al. Electronic monitoring of oral therapies in ethnically diverse and economically disadvantaged patients with rheumatoid arthritis. Consequences of low adherence. Arthritis Rheum. 2013;65:1421–1429. doi:10.1002/art.37917
   PubMed Web of Science ®Google Scholar
• Salt E, Frazier S. Adherence to disease modifying anti-rheumatic drugs in rheumatoid arthritis patients: a narrative review of the literature. Orthop Nurs. 2010;29:260–275. doi:10.1097/NOR.0b013e3181e5c2c9
   PubMed Web of Science ®Google Scholar
• Pasma A, den Boer E, van ’T Spijker A, et al. Nonadherence to disease modifying antirheumatic drugs in the first year after diagnosis: comparing three adherence measures in early arthritis patients. Rheumatology. 2016;55(10):1812–1819. doi:10.1093/rheumatology/kew247
   Web of Science ®Google Scholar
• Michaud K, Vrijens B, Tousset E, et al. Real‐world adherence to oral methotrexate measured electronically in patients with established rheumatoid arthritis. ACR Open Rheumatol. 2019;1:560–570. doi:10.1002/acr2.11079
   PubMedGoogle Scholar
• Pasma A, Schenk CV, Timman R, et al. Non-adherence to disease-modifying antirheumatic drugs is associated with higher disease activity in early arthritis patients in the first year of the disease. Arthritis Res Ther. 2015:1–10. doi:10.1186/s13075-014-0514-0
   Web of Science ®Google Scholar
• Hope HF, Bluett J, Barton A, Hyrich KL, Cordingley L, Verstappen SMM. Psychological factors predict adherence to methotrexate in rheumatoid arthritis; findings from a systematic review of rates, predictors and associations with patient-reported and clinical outcomes. RMD Open. 2016;2:e000171. doi:10.1136/rmdopen-2015-000171
   PubMed Web of Science ®Google Scholar
• Wabe N, Lee A, Wechalekar M, McWilliams L, Proudman S, Wiese M. Adherence to combination DMARD therapy and treatment outcomes in rheumatoid arthritis: a longitudinal study of new and existing DMARD users. Rheumatol Int. 2017;37:897–904. doi:10.1007/s00296-017-3655-z
   Web of Science ®Google Scholar
• Lindqvist E, Jonsson K, Saxne T, Eberhardt K. Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis. Ann Rheum Dis. 2003;62:611–616. doi:10.1136/ard.62.7.611
   PubMed Web of Science ®Google Scholar
• Burgers LE, Raza K, Van der Helm-van Mil AH. Window of opportunity in rheumatoid arthritis – definitions and supporting evidence: from old to new perspectives. RMD Open. 2019;5(1):e000870. doi:10.1136/rmdopen-2018-000870
   PubMed Web of Science ®Google Scholar
• Pasma A, Schenk C, Timman R, et al. Does non-adherence to DMARDs influence hospital-related healthcare costs for early arthritis in the first year of treatment? PLoS One. 2017;12(2):1–14. doi:10.1371/journal.pone.0171070
   Web of Science ®Google Scholar
• Galo JS, Mehat P, Rai SK, Avina-zubieta A, De Vera MA. What are the effects of medication adherence interventions in rheumatic diseases: a systematic review. Ann Rheum Dis. 2016;75(4):667–673. doi:10.1136/annrheumdis-2014-206593
   Web of Science ®Google Scholar
• Demonceau J, Ruppar T, Kristanto P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs. 2013;73(6):545–562. doi:10.1007/s40265-013-0041-3
   PubMed Web of Science ®Google Scholar
• Van Heuckelum M, Van den Ende CHM, Houterman AEJ, Heemskerk CPM, Van Dulmen S, Van den Bemt BJF. The effect of electronic monitoring feedback on medication adherence and clinical outcomes: a systematic review. PLoS One. 2017;12:e0185453. doi:10.1371/journal.pone.0185453
   PubMed Web of Science ®Google Scholar
• Herzer M, Ramey C, Rohan J, Cortina S. Incorporating electronic monitoring feedback into clinical care: a novel and promising adherence promotion approach. Clin Child Psychol Psychiatry. 2011;17:505–518. doi:10.1177/1359104511421103
   Web of Science ®Google Scholar
• St Quinton T, Brunton JA. Implicit processes, self-regulation, and interventions for behavior change. Front Psychol. 2017;8:1–7. doi:10.3389/fpsyg.2017.00346
   Web of Science ®Google Scholar
• Eliasson L, Vrijens B, Clifford S, Mulick A, Jackson C. How the EMERGE guideline on medication adherence can improve the quality of clinical trials. Br J Clin Pharmacol. 2020;86(4):687–697.
   Web of Science ®Google Scholar
• Yeam CT, Chia S, Tan HCC, Kwan YH, Fong W, Seng JJB. A systematic review of factors affecting medication adherence among patients with osteoporosis. Osteoporos Int. 2018;29(12):2623–2637. doi:10.1007/s00198-018-4759-3
   PubMed Web of Science ®Google Scholar
• Seng JJB, Tan JY, Yeam CT, Htay H, Foo WYM. Factors affecting medication adherence among pre-dialysis chronic kidney disease patients: a systematic review and meta-analysis of literature. Int Urol Nephrol. 2020;52:903–916. doi:10.1007/s11255-020-02452-8
   PubMed Web of Science ®Google Scholar
• Goh H, Kwan YH, Seah Y, Low LL, Fong W, Thumboo J. A systematic review of the barriers affecting medication adherence in patients with rheumatic diseases. Rheumatol Int. 2017;37:1619–1628. doi:10.1007/s00296-017-3763-9
   Web of Science ®Google Scholar
• Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. World Health Organization; 2003:1–175.
   Google Scholar
• Schulz K, Altman D, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340(mar23 1):c332. doi:10.1136/bmj.c332
   PubMed Web of Science ®Google Scholar
• De geest S, Zullig LL, Dunbar-jacob J, et al. ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Ann Intern Med. 2018;169(1):30–36. doi:10.7326/M18-0543
   PubMed Web of Science ®Google Scholar
• Noordman J, van der Weijden T, van Dulmen S. Communication-related behavior change techniques used in face-to-face lifestyle interventions in primary care: a systematic review of the literature. Patient Educ Couns. 2012;89(2):227–244. doi:10.1016/j.pec.2012.07.006
   PubMed Web of Science ®Google Scholar
• Linn A, van Weert J, Schouten B, Smit E, van Bodegraven A, van Dijk L. Words that make pills easier to swallow: a communication typology to address practical and perceptual barriers to medication intake behavior. Patient Prefer Adherence. 2012;6:871–885. doi:10.2147/PPA.S36195
   Web of Science ®Google Scholar
• de Klerk E, van der Heijde D, van der Tempel H, van der Linden S. Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy. J Rheumatol. 1999;26:2635–2641.
   PubMed Web of Science ®Google Scholar
• de Klerk E, van der Heijde D, Landewé R, van der Tempel H, van der Linden S. The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study. J Rheumatol. 2003;30:2469–2475.
   PubMed Web of Science ®Google Scholar
• Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14:1–24. doi:10.1080/08870449908407311
   Web of Science ®Google Scholar
• Horne R, Chapman SCE, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the necessity-concerns framework. PLoS One. 2013;8:e80633. doi:10.1371/journal.pone.0080633
   PubMed Web of Science ®Google Scholar
• Boers M, Jacobs JWG, Van Vliet Vlieland TPM, Van Riel PLCM. Consensus dutch health assessment questionnaire. Ann Rheum Dis. 2007;132–133. doi:10.1136/ard.2006.059451
   Web of Science ®Google Scholar
• van den Bemt BJF, van den Hoogen FH, Benraad B, Hekster Y, van Riel PL, van Lankveld W. Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs. J Rheumatol. 2009;36(10):2164–2170. doi:10.3899/jrheum.081204
   PubMed Web of Science ®Google Scholar
• Morisky DE, Green L, Levine D. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74. doi:10.1097/00005650-198601000-00007
   PubMed Web of Science ®Google Scholar
• Lane C, Huws-thomas M, Hood K, Rollnick S, Edwards K, Robling M. Measuring adaptations of motivational interviewing: the development and validation of the behavior change counseling index (BECCI). Patient Educ Couns. 2005;56(2):166–173. doi:10.1016/j.pec.2004.01.003
   PubMed Web of Science ®Google Scholar
• Jeffery RA, Navarro T, Wilczynski NL, et al. Adherence measurement and patient recruitment methods are poor in intervention trials to improve patient adherence. J Clin Epidemiol. 2012;67(10):1076–1082. doi:10.1016/j.jclinepi.2014.06.008
   Web of Science ®Google Scholar
• Zwikker HE, van den Ende CH, van Lankveld WG, et al. Effectiveness of a group-based intervention to change medication beliefs and improve medication adherence in patients with rheumatoid arthritis: a randomized controlled trial. Patient Educ Couns. 2014;94(3):356–361. doi:10.1016/j.pec.2013.12.002
   Web of Science ®Google Scholar
• Alili M, Vrijens B, Demonceau J, Evers S, Hiligsmann M. A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence. Br J Clin Pharmacol. 2016;82(1):268–279. doi:10.1111/bcp.12942
   Web of Science ®Google Scholar
• Vrijens B, de Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705. doi:10.1111/j.1365-2125.2012.04167.x
   PubMed Web of Science ®Google Scholar
• van den Bemt B, den Broeder A, van den Hoogen F, et al. Making the rheumatologist aware of patients’ non-adherence does not improve medication adherence in patients with rheumatoid arthritis. Scan J Rheumatol. 2011;40:192–196. doi:10.3109/03009742.2010.517214
   PubMed Web of Science ®Google Scholar
• Van den Bemt BJF, Zwikker HE, Van den Ende CHM. Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Expert Rev Clin Immunol. 2012;8(4):337–351. doi:10.1586/eci.12.23
   PubMed Web of Science ®Google Scholar
• Curtis JR, Bykerk VP, Aassi M, Schiff M. Adherence and persistence with methotrexate in rheumatoid arthritis: a systematic review. J Rheumatol. 2016;43(11):1997–2009. doi:10.3899/jrheum.151212
   PubMed Web of Science ®Google Scholar
• Allemann SS, Nieuwlaat R, Van den Bemt BJF, Hersberger KE, Arnet I. Matching adherence interventions to patient determinants using the theoretical domains framework. Front Pharmacol. 2016;7:1–11. doi:10.3389/fphar.2016.00429
   Web of Science ®Google Scholar
• Gadallah MA, Boulos DNK, Gebrel A, Dewedar S, Morisky DE. Assessment of rheumatoid arthritis patients’ adherence to treatment. Am J Med Sci. 2015;349:151–156. doi:10.1097/MAJ.0000000000000376
   PubMed Web of Science ®Google Scholar